ATAGI review of AstraZeneca COVID vaccines: What GPs need to know The latest advice suggests there is only a ‘tiny’ risk of blood clots in some patients, but does include contraindications for two rare conditions.
GPs advised not to administer asthma biologics alongside COVID vaccine New updates to the Australian Asthma Handbook for the coronavirus vaccine rollout aim to instil confidence in patients with asthma.
Shortened AstraZeneca vaccine training ‘a victory for common sense’ The update has streamlined the process for answering questions and will allow GPs to skip the introductory module entirely.
GPs scramble to navigate vaccine rollouts amid worsening floods Ripped up carpet, towels on the floor and telehealth: How GPs have kept serving their community, even as the torrential rain covering large parts of Australia shows no sign of stopping.
COVID vaccine rollout ‘a sign of how far we’ve come’ Dr Karen Price has a message for Australia’s GPs as they embark upon one of the most important and challenging journeys in general practice history.
Meeting between RACGP President and Prime Minister leads to more support for GPs Scott Morrison and Health Minister Greg Hunt have guaranteed the supply of vaccines to general practice and committed to supporting GP wellbeing following a meeting with Dr Karen Price.
Developers scramble to fix issues with national COVID vaccine booking platform Confusion over the site’s launch date has seen general practices bear the brunt of people demanding coronavirus vaccination appointments.
Peak medical bodies want COVID vaccine booking clarity With general practices already inundated with calls ahead of next week’s rollout, the RACGP and AMA have urged the Federal Government to clarify the process and ‘not build unrealistic expectations’ for patients.
Fears AstraZeneca pause in Europe could give rise to vaccine hesitancy in Australia At least 13 countries have raised the alarm about possible links between the coronavirus vaccine and blood clots. How will GPs address these concerns with patients?
‘No biological reason’ to link blood clots to COVID vaccine Despite this, several European countries have paused their rollout of the Oxford University/AstraZeneca vaccine as a precaution.